Bill Commons

AZ HB 2617

Status unknown

insurance; prostate cancer; cost sharing

Arizona · 2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did AZ HB 2617 pass?

The current status of AZ HB 2617 is not known from the official record. Latest recorded action (2026-03-09): DPA

What is AZ HB 2617 about?

AZ HB 2617 is a bill in the 2026 Regular Session titled “insurance; prostate cancer; cost sharing”.

Who sponsors AZ HB 2617?

Walt Blackman is the primary sponsor of AZ HB 2617.

Introduced
—
Latest action
2026-03-09 — DPA
Bill type
bill
Last updated
—

Sponsors

  • Walt Blackmanprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-03-09

    DPA

    amendment-passage

  2. 2026-02-09

    DPA

    amendment-passage

  3. 2026-01-26

    House Second Reading

    reading-2

  4. 2026-01-22

    House First Reading.

    reading-1

Versions

  • HOUSE - SUB Floor Amend to HHS - Blackman - passedCompare
  • HOUSE - Health & Human ServicesCompare
  • House Engrossed VersionCompare
  • Introduced VersionCompare
  • (document, no version)Compare

Documents

Votes

  • do pass amended

    2026-03-09 · fail · 0-0

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T01:30:07.297133Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=AZ&identifier=HB 2617. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.